Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-50
SponsorNadezhda Women's Health Hospital

About this trial

The behaviour of the endometrium during its receptive phase is highly dependent on the endometrial cell type composition. Each cell type has its role in the endometrial preparation for the invading embryo. Alteration in the immune cells dialogue could be the main reason for unsuccessful implantation in certain patients. Immune cell homeostasis is often improved by intrauterine administration of autologous PBMC.

There have been numerous reports on the positive effects of the intrauterine administration of autologous PBMC on the IVF outcomes (embryo implantation and ongoing pregnancy success). However, there is little data on the direct effect of the PBMC administration on the cell composition of the endometrium. This study will focus on the changes in the endometrial cell populations by PBMC treatment that could lead to IVF outcome improvement.

The aim of this project is to analyze the effect of intrauterine administration of autologous PBMC on the endometrial cell populations and on the IVF outcome parameters (implantation and ongoing pregnancy success as IVF outcome variables).

Eligibility criteria

Qualifiers

Participating in Assisted Reproduction Treatment

Presenting altered endometrial immune profile

Having primary infertility

Having regular menstrual cycles

Disqualifiers

Uterine pathologies

Endometrial Bacterial infections

Active endometrial inflammation

Polycystic ovary syndrome

Trial design

Treatments tested in this trial

  • Intrauterine administration of autologous peripheral blood mononuclear cells (PBMC)

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators

Nadezhda Women's Health Hospital

Lead sponsor

Medical diagnostic laboratory ImunoVita

Collaborator